Puas yog koj tab tom nrhiav rau qhov zoo tshaj plaws Oleoylethanolamide (OEA) hmoov tsum? Nrog nws cov txiaj ntsig zoo rau kev tswj hwm qhov hnyav thiab kev noj qab haus huv tag nrho, nws tsis xav tias ntau tus neeg txaus siab rau qhov sib xyaw no. Txawm li cas los xij, thaum yuav OEA hmoov, nws yog ib qho tseem ceeb los xyuas kom meej tias koj tau txais cov khoom zoo uas ua tau raws li koj cov kev xav tau. Yog li kev yuav khoom zoo oleoylethanolamide hmoov yuav tsum tau ua tib zoo xav txog tus neeg muag khoom, purity, potency, daim ntawv, thiab nqe. Los ntawm kev txiav txim siab txog cov xwm txheej no thiab nrhiav kev tawm tswv yim, koj tuaj yeem txiav txim siab paub thiab xaiv los txhawb koj lub lag luam nrog cov hmoov zoo OEA.
Hauv kev kho mob, muaj ntau suav tsis txheeb thiab cov ntsiab lus uas tuaj yeem ua rau cov neeg tsis paub nrog thaj chaw. Ntau tus neeg yuav tsis paub txog lub sijhawm:Oleylethanolamide (OEA). Dab tsi yog OEA los ntawm kev xav txog kev kho mob? Vim li cas thiaj tseem ceeb kom nkag siab txog nws?
Cia peb nkag siab luv luv txog cov qauv thiab cov khoom ntawm OEA!
Qauv
Oleic acid ethanolamide, los yog Oleoylethanolamide (OEA), yog ib tug tswv cuab ntawm endogenous cannabinoids. Nws yog ib qho chaw nruab nrab amide compound uas muaj lipophilic oleic acid thiab hydrophilic ethanolamine. OEA kuj yog ib qho lipid molecule tshwm sim nyob rau hauv lwm yam tsiaj thiab cov ntaub so ntswg. Nws yog dav nyob rau hauv cov tsiaj thiab cov ntaub so ntswg xws li cocoa hmoov, soybeans, thiab txiv ntseej, tab sis nws cov ntsiab lus tsis tshua muaj heev. Tsuas yog thaum ib puag ncig sab nraud hloov pauv lossis cov zaub mov raug txhawb nqa, lub cev cov ntaub so ntswg ntawm tes tsuas yog tom qab ntawd yuav tsim cov tshuaj no ntau dua.
Xwm
Nyob rau hauv chav tsev kub, OEA yog cov khoom dawb nrog lub melting point ntawm txog 50 ° C. Nws yog yooj yim soluble nyob rau hauv cawv kuab tshuaj xws li methanol thiab ethanol, yooj yim soluble nyob rau hauv non-polar solvents xws li n-hexane thiab ether, thiab insoluble nyob rau hauv dej. OEA yog ib qho amphiphilic molecule ib txwm siv los ua surfactant thiab xab npum hauv kev lag luam tshuaj. Txawm li cas los xij, kev tshawb fawb ntxiv tau pom tias OEA tuaj yeem ua lub luag haujlwm lipid signaling molecule nyob rau hauv lub plab-hlwb axis thiab tso tawm ntau cov haujlwm lom hauv lub cev, suav nrog: tswj kev qab los noj mov, txhim kho lipid metabolism, txhim kho kev nco thiab kev paub thiab lwm yam haujlwm. Ntawm lawv, OEA lub luag haujlwm ntawm kev tswj kev qab los noj mov thiab txhim kho lipid metabolism tau txais kev mloog zoo tshaj plaws.
Oleylethanolamide (OEA) yog lub ntuj fatty acid derivative tsim nyob rau hauv txoj hnyuv me. Nws belongs rau ib chav kawm ntawm cov tebchaw hu ua endocannabinoids. Endogenously ua Oleoylethanolamide (OEA) yog ib txwm tshwm sim lipid molecule uas ua lub luag haujlwm tseem ceeb hauv ntau yam txheej txheem physiological hauv lub cev. Nws yog cais raws li bioactive lipid thiab yog ib feem ntawm endocannabinoid system, ib tug complex network ntawm signaling molecules thiab receptors koom nyob rau hauv regulating ntau lub cev functions, xws li qab los noj mov, Metabolism, mob, thiab o.
OEA tuaj yeem tswj hwm kev noj zaub mov thiab lub zog homeostasis los ntawm kev ua kom peroxisome proliferator-activated receptor-α. Tsis tas li ntawd, OEA nthuav tawm lwm cov haujlwm ntsig txog kev noj qab haus huv, suav nrog kev hloov pauv hloov pauv kev ua haujlwm hauv lysosomal-rau-nuclear signaling txoj hauv kev cuam tshuam nrog kev tswj kav ntev thiab tiv thaiv cov hlab ntsha uas tswj kev ntxhov siab.
Kev tshawb fawb tsis ntev los no kuj qhia tias OEA yuav muaj cov teebmeem neuroprotective. Hauv cov qauv tsiaj, nws tau pom tias txo kev puas tsuaj los ntawm kev mob stroke thiab kev puas hlwb puas tsuaj.
Kev tswj hwm cov txiaj ntsig ntawm OEA yog ntaus nqi rau nws txoj kev khi rau PPARα, uas dimerizes nrog retinoid X receptor (RXR) thiab ua kom nws ua lub zog hloov pauv uas cuam tshuam nrog kev sib xyaw ntawm lub zog homeostasis, lipid metabolism, autophagy, thiab o. downstream lub hom phiaj.
Txawm li cas los xij, OEA cov ntsiab lus tsis tshua muaj siab thiab nyuaj kom tau txais ncaj qha los ntawm cov khoom noj, yog li yuav tsum tau tsim cov peev txheej OEA ntxiv. Ntawm lawv, chemical synthesis thiab biological transformation reactions yog qhov tam sim no tau txais OEA. Ntawm lawv, Suzhou Mailun Biotechnology tsim cov purity siab, zoo OEA los ntawm cov tshuaj synthesis.
Cov txheej txheem synthesis ntawm OEA feem ntau suav nrog ob txheej txheem: kev sib txuas ntawm phospholipid-derived N-oleoylphosphatidylethanolamine (NOPE) thiab tom qab hloov pauv ntawm NOPE rau hauv OEA. Lub shunt ntawm NAS lossis NAT yog koom nrog hauv kev tsim NOPE, thaum OEA tuaj yeem tsim los ntawm ntau txoj hauv kev, ntawm cov phospholipase D (PLD) yog txoj hauv kev ncaj qha tshaj plaws.
PEA, luv rauPalmitoylethanolamide (PEA), yog fatty acid amide uas yog tsim los ntawm lub cev nyob rau hauv teb rau o thiab mob. Nws kuj tseem pom muaj nyob hauv qee yam khoom noj, tshwj xeeb tshaj yog cov nplua nuj nyob hauv cov rog zoo li qe, taum pauv, thiab txiv laum huab xeeb. PEA tau kawm txog nws cov peev xwm los tiv thaiv kab mob thiab tshuaj tua kab mob, ua rau nws muaj txiaj ntsig zoo ntxiv rau cov neeg mob mob, mob caj dab, thiab lwm yam mob.
OEA (los yog oleoylethanolamide), ntawm qhov tod tes, yog lipid molecule uas tsim nyob rau hauv txoj hnyuv me. Nws lub luag haujlwm tseem ceeb yog tswj kev qab los noj mov thiab lub cev hnyav los ntawm kev cuam tshuam nrog endocannabinoid system. Paub txog nws lub peev xwm los txhawb kev satiety thiab txo cov zaub mov noj, Oleoylethanolamide (OEA) yog ib qho kev cog lus rau cov neeg nrhiav kev txhawb nqa kev tswj qhov hnyav thiab kev noj qab haus huv.
Ib qho ntawm qhov sib txawv tseem ceeb ntawm PEA thiab Oleoylethanolamide(OEA) yog lawv cov txheej txheem ntawm kev txiav txim thiab cov kab ke hauv lub cev lawv lub hom phiaj. PEA feem ntau ua rau txoj kev mob thiab kev nkag siab ntawm qhov mob, thaum OEA tsom mus rau kev noj qab haus huv cov cai thiab lub zog sib npaug. Qhov kev sib txawv no yog qhov tseem ceeb thaum xav txog cov txiaj ntsig zoo ntawm txhua qhov sib xyaw thiab yuav siv lawv li cas los daws cov teeb meem kev noj qab haus huv tshwj xeeb.
Hais txog cov txiaj ntsig kev noj qab haus huv, PEA tau kawm txog nws lub luag haujlwm hauv kev kho mob ntev xws li fibromyalgia, neuropathy, thiab sciatica. Nws cov khoom tiv thaiv kab mob ua rau nws muaj txiaj ntsig zoo rau cov tib neeg nrhiav lwm txoj hauv kev rau cov tswv yim tswj kev mob. Tsis tas li ntawd, PEA qhia cov lus cog tseg hauv kev txhawb nqa kev noj qab haus huv ntawm daim tawv nqaij thiab kev tiv thaiv kab mob, ntxiv kev nthuav dav nws cov peev txheej hauv kev txhawb nqa kev noj qab haus huv tag nrho.
Ntawm qhov tod tes, lub luag haujlwm ntawm Oleoylethanolamide (OEA) hauv kev tswj kev noj qab haus huv thiab kev tswj qhov hnyav tau ua rau muaj kev cuam tshuam txog kev rog rog thiab cov kab mob metabolic. Kev tshawb fawb qhia tau hais tias Oleoylethanolamide (OEA) yuav pab tswj cov zaub mov cravings, txo overeating, thiab txhawb ib tug noj qab nyob zoo metabolism, ua rau nws yog ib qho tseem ceeb cov cuab yeej rau cov tib neeg nrhiav kom ua tiav thiab tswj lub cev hnyav. Tsis tas li ntawd, OEA qhov kev cuam tshuam nrog endocannabinoid system qhia txog nws qhov cuam tshuam rau kev xav thiab kev xav noj mov.
Txawm hais tias Palmitoylethanolamide (PEA) thiab Oleoylethanolamide (OEA) muaj qhov sib txawv thiab cov txiaj ntsig zoo, nws yog ib qho tseem ceeb uas yuav tsum nco ntsoov tias lawv tsis sib koom ua ke. Qhov tseeb, qee tus neeg yuav pom muaj txiaj ntsig hauv kev sib txuas ob qho tib si rau hauv lawv cov kev noj qab haus huv los daws ntau yam ntawm lawv txoj kev noj qab haus huv. Piv txwv li, cov neeg uas muaj mob ntev thiab cov teeb meem tswj qhov hnyav tuaj yeem tau txais txiaj ntsig los ntawm PEA cov tshuaj tiv thaiv kab mob nrog rau OEA cov txiaj ntsig kev noj qab haus huv.
Kev noj qab haus huv thiab tswj qhov hnyav
Nyob rau hauv xyoo tas los no, oleoylethanolamide tau dhau los ua neeg nyiam ua kev noj haus ntxiv rau kev poob phaus. Kev tshawb fawb qhia tias OEA tuaj yeem pab txo qis qab los noj mov, ua rau txo qis kev noj zaub mov thiab poob phaus ntxiv.
OEA yog ib qho tseem ceeb noj zaub mov inhibitor uas nws lub luag haujlwm tseem ceeb yog los pab txo kev rog. Kev txhaj tshuaj Intraperitoneal ntawm OEA tuaj yeem txo cov khoom noj thiab qhov hnyav nce hauv nas. Lub ntsiab yuag poob ntawm OEA yog tias nws tuaj yeem ua rau muaj kev xav ntawm satiety, yog li tswj kev noj zaub mov ntau dhau. Ntxiv qee qhov concentration ntawm OEA rau kev pub noj ntawm cov nas ib txwm muaj lossis rog tuaj yeem txo cov nas qab los noj mov thiab qhov hnyav.
OEA tuaj yeem tsis tsuas yog inhibit plab hnyuv plab zom mov, tab sis kuj tseem ua kom cov beta oxidation ntawm fatty acids los ntawm kev txhawb nqa cov hydrolysis ntawm triglycerides hauv cov ntaub so ntswg peripheral (siab thiab rog), thaum kawg txo cov rog thiab ua tiav kev tswj qhov hnyav.
Tsis tas li ntawd, OEA ua rau PPAR receptors nyob rau hauv cov hnyuv me, pab txo qis qab los noj mov thiab ua kom cov rog hauv lub cev. Cov nyhuv metabolic ntawm OEA no ua rau muaj kev siv zog ntau ntxiv, uas yog qhov tseem ceeb rau kev poob phaus.
Ntxiv rau kev tswj kev qab los noj mov, OEA hmoov txhawb kev noj qab haus huv metabolism. Kev tshawb fawb qhia tau hais tias OEA tuaj yeem pab txhawb lub cev kev siv hluav taws xob, uas tuaj yeem ua rau cov metabolic nce ntxiv. Los ntawm kev txhawb nqa lipolysis thiab txhim kho kev siv lub zog, OEA hmoov tuaj yeem pab txhawb cov neeg saib xyuas kom noj qab haus huv thiab cov metabolism.
Kev tswj kev xav thiab kev ntxhov siab
Oleoylethanolamide (OEA) tau pom tias muaj txiaj ntsig zoo hauv kev txo qis kev ntxhov siab thiab kev ntxhov siab hauv lub cev. OEA pab tswj kev tsim cov tshuaj hormones kev ntxhov siab xws li cortisol, yog li txo qis kev ntxhov siab thiab kev ntxhov siab.
Kev tshawb fawb qhia tau hais tias OEA pab qhib PPAR receptors nyob rau hauv amygdala, ib feem ntawm lub hlwb lub luag hauj lwm rau tswj kev ntxhov siab vim thiab kev ntxhov siab. Qhov kev ua kom no ua rau txo qis kev ntxhov siab thiab ntxhov siab. Pab txo kev ntxhov siab thiab txhawb kev noj qab haus huv.
Tsis tas li ntawd, OEA tau txuas nrog rau kev tswj hwm qib dopamine hauv lub hlwb, uas tuaj yeem ua lub luag haujlwm hauv kev tswj hwm kev xav thiab kev noj qab haus huv tag nrho.
Inflammation thiab tiv thaiv kev ua haujlwm
Kev mob ntev yog txuas nrog ntau yam teeb meem kev noj qab haus huv, suav nrog kev rog rog, ntshav qab zib thiab kab mob plawv. Oleoylethanolamide (OEA) tau pom tias pab txo qhov mob hauv lub cev.
Kev tshawb fawb qhia tias OEA pab txo qis kev tsim cov cytokines, uas yog cov cim ntawm kev mob hauv lub cev. OEA kuj tseem pab txo qis oxidative kev nyuaj siab, ua rau mob loj hauv lub cev.
Oleoylethanolamide (OEA) qhia cov lus cog tseg hauv kev hloov kho cov lus teb inflammatory hauv lub cev, uas tuaj yeem cuam tshuam rau kev tiv thaiv kab mob thiab tiv thaiv kab mob. Oleoylethanolamide (OEA) hmoov tuaj yeem muab cov txiaj ntsig kev noj qab haus huv mus ntev los ntawm kev txhawb nqa kev noj qab haus huv inflammatory teb.
Txo cov ntshav lipids thiab tiv thaiv atherosclerosis
Peroxisome proliferator-activated receptor-α (PPAR-α) yog ib hom receptor ze ze rau lub cev metabolic zog. PPAR-α koom nrog hauv lipid metabolism los ntawm kev khi rau peroxisome proliferator teb cov ntsiab lus. Kev thauj mus los ntawm metabolic, kev tiv thaiv kab mob, tiv thaiv kab mob, tiv thaiv kev loj hlob thiab lwm yam txheej txheem ntxiv ua lub luag haujlwm hauv kev tswj cov ntshav lipids thiab tiv thaiv atherosclerosis.
Oleoylethanolamide (OEA) yog ib qho endocannabinoid analog uas tau tsim thaum lub cev nqaij daim tawv raug txhawb. Cov kev tshawb fawb tau pom tias OEA ua kom PPAR-M, txo cov kev tso tawm ntawm endothelin-1, inhibits vasoconstriction thiab du cov leeg cell proliferation, txhawb vasodilation, thiab nyob rau tib lub sij hawm nce lub synthesis ntawm endothelial nitric oxide synthase thiab induces zus tau tej cov nitric oxide ntau. synthase. nitrogen, yog li txo qhov tsim ntawm vascular cell adhesion molecules, ua tiav cov teebmeem los tiv thaiv, thiab ua kom cov teebmeem ntawm cov ntshav lipid txo qis thiab tiv thaiv atherosclerosis.
Lub hlwb noj qab haus huv thiab kev txawj ntse muaj nuj nqi
Kev tshawb fawb qhia tias OEA hmoov kuj tseem tuaj yeem cuam tshuam rau lub hlwb kev noj qab haus huv thiab kev paub txog kev ua haujlwm. Oleoylethanolamide (OEA) tau pom tias hla cov ntshav-hlwb thaiv thiab cuam tshuam nrog cov receptors hauv lub hlwb, ua rau muaj peev xwm cuam tshuam rau kev paub txog kev ua haujlwm thiab kev tiv thaiv neuroprotection.
Nws tsim nyog hais tias OEA tuaj yeem cuam tshuam txog kev nce qib AD. Lub amyloid-beta (Aβ) pathology ntawm Alzheimer's disease (AD) yog nrog los ntawm kev hloov pauv tseem ceeb hauv glial hlwb hauv lub hlwb. Cov kev tshawb fawb ntawm genome-wide koom haum tau pom tias microglia thiab lawv txoj kev cuam tshuam, xws li phagocytosis, lipid metabolism, thiab kev tiv thaiv kab mob, ua lub luag haujlwm tseem ceeb hauv etiology ntawm lig pib AD.
Oleylethanolamine (OEA) yog ib qho evolutionarily conserved endogenous lipid molecule uas tau pom tias yuav ncua lifespan thiab noj qab haus huvspan nyob rau hauv C. elegans. Hauv cov tsiaj nyeg, OEA yog tsim nyob rau hauv cov ntaub so ntswg thiab lub hauv nruab nrab lub paj hlwb, thiab kev tshawb fawb lipidomics pom tias OEA thiab lwm yam fatty acids ethanolamine tau txo qis hauv cov kua cerebrospinal thiab ntshav ntawm cov neeg mob AD, txhais tau hais tias cov molecules xws li OEA tuaj yeem cuam tshuam AD. .
1. Paub qhov chaw thiab purity
Thaum muas Oleoylethanolamide (OEA) hmoov, koj yuav tsum xav txog qhov chaw thiab purity ntawm cov khoom. Nrhiav cov neeg muag khoom muaj npe nrov uas siv cov khoom xyaw zoo thiab ua raws li cov qauv tsim khoom nruj. Qhov zoo tshaj plaws, OEA hmoov yuav tsum tau muab los ntawm cov khoom siv ntuj tsim thiab muaj purity siab los xyuas kom meej nws cov txiaj ntsig thiab kev nyab xeeb.
2. Txheeb xyuas qhov kev xeem thib peb
Txhawm rau kom ntseeg tau tias qhov zoo thiab purity ntawm Oleoylethanolamide (OEA) hmoov, nws yog ib qho tseem ceeb uas yuav tau xaiv cov khoom uas tau raug kuaj los ntawm peb lub chaw soj nstuam. Kev ntsuam xyuas thib peb kom ntseeg tau tias OEA cov hmoov tsis muaj cov kab mob thiab ua tau raws li qhov muaj peev xwm thiab qib purity. Saib rau cov khoom uas muab cov txiaj ntsig kev sim pob tshab thiab pov thawj, muab kev thaj yeeb rau koj lub siab txog qhov zoo ntawm OEA hmoov koj yuav.
3. Xav txog daim ntawv qhia
Oleoylethanolamide (OEA) hmoov muaj nyob rau hauv ntau yam formulations, nrog rau cov tshuaj ntsiav thiab hmoov. Thaum xaiv cov qauv uas haum rau koj, xav txog koj qhov kev nyiam thiab kev ua neej. Capsules muab kev siv yooj yim thiab meej, thaum hmoov thiab kua tuaj yeem sib xyaw yooj yim rau hauv dej qab zib lossis zaub mov.
4. Ntsuas cov khoom lag luam lub koob npe nrov
Thaum yuav OEA hmoov, nws yog ib qho tseem ceeb uas yuav tsum tau yuav los ntawm ib tus neeg muag khoom muaj npe nrov thiab muaj kev ntseeg siab. Tshawb nrhiav tus neeg muag khoom lub koob npe nrov, kev tshuaj xyuas cov neeg siv khoom, thiab cov ntawv pov thawj kom ntseeg tau tias koj tau txais cov khoom lag luam txhim khu kev qha thiab zoo. Tus neeg muag khoom muaj npe nrov yuav ua pob tshab txog lawv cov khoom siv, kev tsim khoom, thiab cov khoom zoo, muab kev ntseeg siab rau koj qhov kev yuav khoom.
5. Ntsuas tus nqi thiab tus nqi
Thaum tus nqi yuav tsum tsis yog qhov kev txiav txim siab nkaus xwb, nws tseem ceeb heev uas yuav tsum xav txog tus nqi ntawm OEA hmoov koj tab tom yuav. Sib piv cov nqi los ntawm cov neeg muag khoom sib txawv, suav nrog cov khoom lag luam hauv paus, purity, formulation thiab lub koob npe nrov. Nco ntsoov tias cov hmoov zoo OEA tej zaum yuav kim dua, tab sis tus nqi nws muab raws li kev ua tau zoo thiab kev nyab xeeb yog tsim nyog rau kev nqis peev.
6. Tham nrog ib tug kws kho mob
Ua ntej ntxiv OEA hmoov rau koj cov txheej txheem ntxiv, nws raug nquahu kom sab laj nrog kws kho mob, tshwj xeeb tshaj yog tias koj muaj mob hauv qab lossis noj tshuaj. Tus kws kho mob tuaj yeem muab kev taw qhia tus kheej thiab xyuas kom OEA tsim nyog rau koj txoj kev noj qab haus huv txhua hnub.
Ploj mus yog hnub thaum koj tsis paub qhov twg yuav Oleoylethanolamide (OEA). Lub hustle thiab bustle rov qab thaum ntawd yog tiag. Koj yuav tsum mus ntawm lub khw mus rau lub khw muag khoom, mus rau cov khw muag khoom loj, khw muag khoom, thiab nug txog cov khoom koj nyiam. Qhov phem tshaj plaws uas tuaj yeem tshwm sim yog taug kev txhua hnub thiab tsis tau txais qhov koj xav tau. Qhov phem tshaj, yog tias koj tau txais cov khoom no, koj yuav xav tias nyuaj rau yuav cov khoom ntawd.
Niaj hnub no, muaj ntau qhov chaw yuav Oleoylethanolamide (OEA) hmoov. Ua tsaug rau internet, koj tuaj yeem yuav txhua yam yam tsis tau tawm hauv koj lub tsev. Ua hauv online tsis tsuas yog ua rau koj txoj haujlwm yooj yim dua, nws tseem ua rau koj txoj kev yuav khoom yooj yim dua. Koj kuj muaj sij hawm los nyeem ntxiv txog qhov no amazing ntxiv ua ntej txiav txim siab yuav nws.
Muaj ntau tus neeg muag khoom hauv online niaj hnub no thiab nws yuav nyuaj rau koj xaiv qhov zoo tshaj plaws. Qhov koj yuav tsum paub yog tias thaum lawv txhua tus yuav cog lus kub, tsis yog txhua tus yuav xa.
Yog tias koj xav yuav Oleoylethanolamide (OEA) hmoov hauv ntau, koj tuaj yeem tso siab rau peb. Peb muab cov kev pabcuam zoo tshaj plaws uas yuav xa cov txiaj ntsig. Txiav txim los ntawm Suzhou Myland Pharm hnub no thiab pib koj txoj kev mus rau kev noj qab haus huv zoo.
Suzhou Myland Pharm & Nutrition Inc. tau koom nrog kev lag luam khoom noj khoom haus ntxiv txij li xyoo 1992. Nws yog thawj lub tuam txhab hauv Suav teb los tsim thiab ua lag luam txiv hmab txiv ntoo extract.
Nrog 30 xyoo ntawm kev paub thiab tsav los ntawm cov cuab yeej siv siab thiab lub tswv yim zoo R & D, lub tuam txhab tau tsim ntau yam khoom sib tw thiab dhau los ua lub neej tshiab kev tshawb fawb ntxiv, kev cai synthesis thiab tsim cov tuam txhab.
Tsis tas li ntawd, Suzhou Myland Pharm & Nutrition Inc. kuj yog ib lub chaw tsim tshuaj paus FDA. Lub tuam txhab R&D cov peev txheej, cov chaw tsim khoom, thiab cov cuab yeej tshuaj ntsuam xyuas yog niaj hnub thiab muaj ntau yam thiab tuaj yeem tsim cov tshuaj los ntawm milligrams mus rau tons hauv nplai, thiab ua raws li ISO 9001 cov qauv thiab cov khoom siv tshwj xeeb GMP.
Q: Oleoylethanolamide (OEA) hmoov yog dab tsi thiab nws ua haujlwm li cas?
A: Oleoylethanolamide (OEA) hmoov yog lub ntuj lipid molecule uas tsim nyob rau hauv txoj hnyuv me. Nws ua haujlwm los ntawm kev ua kom cov peroxisome proliferator-activated receptor alpha (PPAR-α), uas ua lub luag haujlwm hauv kev tswj cov metabolism thiab txhawb kev xav ntawm kev puv.
Q: Cov txiaj ntsig zoo ntawm kev siv Oleoylethanolamide (OEA) hmoov yog dab tsi?
A: Qee qhov txiaj ntsig zoo ntawm kev siv OEA hmoov muaj xws li kev noj qab haus huv, tswj kev hnyav, thiab txhawb kev noj qab haus huv metabolism. Nws kuj tseem muaj cov tshuaj tiv thaiv kab mob thiab neuroprotective.
Q: Kuv yuav xaiv cov hmoov zoo Oleoylethanolamide (OEA) li cas?
A: Thaum xaiv OEA hmoov, nws yog ib qho tseem ceeb uas yuav tau nrhiav ib tus neeg muag khoom muaj npe nrov uas muab kev ntsuam xyuas thib peb rau kev purity thiab potency. Tsis tas li ntawd, xav txog lub hauv paus ntawm cov hmoov thiab xaiv cov khoom uas tau muab los ntawm ntuj tsim, ruaj khov.
Kev lees paub: Kab lus no yog rau cov ntaub ntawv dav dav nkaus xwb thiab yuav tsum tsis txhob raug txhais raws li cov lus qhia kho mob. Qee cov ntaub ntawv blog tshaj tawm los ntawm Is Taws Nem thiab tsis yog kev tshaj lij. Lub vev xaib no tsuas yog lub luag haujlwm rau kev txheeb xyuas, formatting thiab kho cov ntawv. Lub hom phiaj ntawm kev xa cov ntaub ntawv ntau ntxiv tsis txhais tau hais tias koj pom zoo nrog nws cov kev xav lossis lees paub qhov tseeb ntawm nws cov ntsiab lus. Nco ntsoov sab laj nrog tus kws kho mob ua ntej siv cov tshuaj ntxiv lossis hloov pauv koj txoj kev kho mob.
Post lub sij hawm: Aug-23-2024
